Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2008-001319-39-IT
EUCTR2008-001319-39-IT
Active, not recruiting
Not Applicable

PROtection of coronary Microcirculation by Iloprost:Safety and Efficacy in Percutaneous Coronary Intervention - PROMISE PCI

AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI0 sitesJuly 8, 2008
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
DrugsENDOPROST*INFUS 1F 0,05MG/0,5M

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
Status
Active, not recruiting
Last Updated
12 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 8, 2008
End Date
TBD
Last Updated
12 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI

Eligibility Criteria

Inclusion Criteria

  • •Inclusion Criteria
  • •1\.Age \> 18 y
  • •2\.Stable angina or inducible ischemia
  • •3\.Acute myocardial infarction without ST elevation (NSTEMI)
  • •4\.Planned angioplasty on one, two or three coronary lesions
  • •5\.Informed Consent
  • •Subgroup with coronary flow study
  • •Acute myocardial infarction without ST elevation (NSTEMI)
  • •Planned angioplasty on only one stenosis or on double lesion on single vessel
  • •Are the trial subjects under 18? no

Exclusion Criteria

  • •Exclusion Criteria
  • •1\.Atrial fibrillation (cases with coronary flow study)
  • •2\.ST elevation acute myocardial infarction (STEMI)
  • •3\.Contraindications to anti\-platelet therapy or IIb/IIIa inhibitors
  • •4\.Hypertension (\> 180/100 mmHg)
  • •5\.Planned angioplasty on more than three coronary stenoses
  • •6\.Two or more of the following procedural characteristics: stenoses in coronary bifurcations, multiple stenoses, stenoses in saphenous aorto\-coronary grafts
  • •7\.Pregnancy or fertile age
  • •Subgroup with coronary flow study
  • •Atrial fibrillation

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
PROtection of coronary Microcirculation by Iloprost:Safety and Efficacy evaluation in PCI - PROMISEcoronary angioplastyMedDRA version: 9.1Level: LLTClassification code 10050329Term: Coronary angioplasty
EUCTR2006-002726-32-ITAZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
Active, not recruiting
Phase 1
Protective effect of antiplatelet drug Ticagrelor compared to antiplatelet drug Clopidogrel on small heart vessels in diabetic patient with anginaIschemic Heart Disease in Diabetic patientsMedDRA version: 18.1 Level: PT Classification code 10072685 Term: Microvascular coronary artery disease System Organ Class: 10007541 - Cardiac disordersTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2015-003621-33-ESFundación Interhospitalaria de Investigación Cardiovascular50
Active, not recruiting
Not Applicable
Influence on the coronary Microcirculation and on myocArdial perfusion Reserve of Niaspan given IN addition to simvastatin in diabEtic patients - MARINE
EUCTR2006-000569-13-DECardioangiologisches Centrum Bethanien40
Active, not recruiting
Not Applicable
PROMISE AMI (PROtection of coronary Microcirculation by Iloprost: Safety and Efficacy evaluation in Acute Myocardial Infarction treated by primary PCI) Pilot Study - Promise AMI
EUCTR2008-001325-34-ITAZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
Completed
Not Applicable
Coronary Microcirculatory and Bioresorbable Vascular ScaffoldsCHD - Coronary Heart DiseaseAngina, StableMyocardial Ischemia
NCT03076476Papworth Hospital NHS Foundation Trust36